Stem Cell Treatment

Eva Feldman

FDA Approves Phase II Of U-M Stem Cell Trial For ALS

For nearly two years, University of Michigan neurologist Eva Feldman, M.D., has led the nation’s first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig’s disease.

WWJ Newsradio 950–04/17/2013


Henry Ford First In Michigan To Use Stem Cells To Preserve Heart Function

Physicians at Henry Ford Hospital are the first in Michigan in a new national research study to investigate treating a recent heart attack with a patient’s own stem cells to preserve heart muscle function.

WWJ Newsradio 950–01/07/2013


Oakland University Stem Cell Conference Talks Cures

At least 300 people attended the weekend’s Second Midwest Conference On Stem Cell Biology and Therapy Friday through Sunday at Oakland University.

WWJ Newsradio 950–10/07/2012

University of Michigan Hospital (University of Michigan photo)

ALS Patients Approved For More Stem Cells

Three patients with amyotrophic lateral sclerosis will be permitted to receive a second dose of stem cells delivered directly to the spinal cord, in a clinical trial being led by the University of Michigan’s Eva Feldman, M.D.

WWJ Newsradio 950–05/09/2012


Get every new post delivered to your Inbox.

Join 3,250 other followers